These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 6157049)

  • 1. Proteinuria and functional characteristics of the glomerular barrier in diabetic nephropathy.
    Carrie BJ; Myers BD
    Kidney Int; 1980 May; 17(5):669-76. PubMed ID: 6157049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of proteinuria in diabetic nephropathy. II. A study of the size-selective glomerular filtration barrier.
    Friedman S; Jones HW; Golbetz HV; Lee JA; Little HL; Myers BD
    Diabetes; 1983 May; 32 Suppl 2():40-6. PubMed ID: 6086024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of exercise on glomerular passage of macromolecules in patients with diabetic nephropathy and in healthy subjects.
    Ala-Houhala I
    Scand J Clin Lab Invest; 1990 Feb; 50(1):27-33. PubMed ID: 1690442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fractional dextran and protein clearances in glomerulonephritis and in diabetic nephropathy.
    Ala-Houhala I; Pasternack A
    Clin Sci (Lond); 1987 Mar; 72(3):289-96. PubMed ID: 2434282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Charge selectivity of proteinuria in diabetic glomerulopathy.
    Nakamura Y; Myers BD
    Diabetes; 1988 Sep; 37(9):1202-11. PubMed ID: 3410164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of proteinuria in diabetic nephropathy: a study of glomerular barrier function.
    Myers BD; Winetz JA; Chui F; Michaels AS
    Kidney Int; 1982 Apr; 21(4):633-41. PubMed ID: 6178872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional nature of glomerular injury in progressive diabetic glomerulopathy.
    Tomlanovich S; Deen WM; Jones HW; Schwartz HC; Myers BD
    Diabetes; 1987 May; 36(5):556-65. PubMed ID: 2436961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glomerular function in advanced human diabetic nephropathy.
    Winetz JA; Golbetz HV; Spencer RJ; Lee JA; Myers BD
    Kidney Int; 1982 May; 21(5):750-6. PubMed ID: 6180214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Converting enzyme inhibition and glomerular size selectivity in diabetic nephropathy.
    Meyer TW; Morelli E; Loon N; Peters W; Myers BD
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S64-8. PubMed ID: 16989068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glomerular size- and charge selectivity in type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy.
    Gall MA; Rossing P; Kofoed-Enevoldsen A; Nielsen FS; Parving HH
    Diabetologia; 1994 Feb; 37(2):195-201. PubMed ID: 8163055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glomerular permeability to neutral and anionic dextrans in experimental diabetes.
    Michels LD; Davidman M; Keane WF
    Kidney Int; 1982 May; 21(5):699-705. PubMed ID: 6180213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of proteinuria in human glomerulonephritis.
    Myers BD; Okarma TB; Friedman S; Bridges C; Ross J; Asseff S; Deen WM
    J Clin Invest; 1982 Oct; 70(4):732-46. PubMed ID: 6181095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of the puromycin-induced defects in the transglomerular passage of water and macromolecules.
    Bohrer MP; Baylis C; Robertson CR; Brenner BM; Troy JL; Willis WT
    J Clin Invest; 1977 Jul; 60(1):152-61. PubMed ID: 874080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of atrial natriuretic peptide on renal and vascular permeability in diabetes mellitus.
    Zietse R; Derkx FH; Weimar W; Schalekamp MA
    J Am Soc Nephrol; 1995 Jun; 5(12):2057-66. PubMed ID: 7579054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of converting-enzyme inhibition on barrier function in diabetic glomerulopathy.
    Morelli E; Loon N; Meyer T; Peters W; Myers BD
    Diabetes; 1990 Jan; 39(1):76-82. PubMed ID: 1698674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permselectivity of the glomerular capillary wall: III. Restricted transport of polyanions.
    Chang RL; Deen WM; Robertson CR; Brenner BM
    Kidney Int; 1975 Oct; 8(4):212-8. PubMed ID: 1202253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glomerular permselectivity in early stages of overt diabetic nephropathy.
    Andersen S; Blouch K; Bialek J; Deckert M; Parving HH; Myers BD
    Kidney Int; 2000 Nov; 58(5):2129-37. PubMed ID: 11044234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology of proteinuria in diabetic glomerular disease.
    Myers BD
    J Hypertens Suppl; 1990 Mar; 8(1):S41-6. PubMed ID: 2332816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal change nephropathy: an electrochemical disorder of the glomerular membrane.
    Carrie BJ; Salyer WR; Myers BD
    Am J Med; 1981 Feb; 70(2):262-8. PubMed ID: 6162382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in heparan sulfate correlate with increased glomerular permeability.
    Groggel GC; Stevenson J; Hovingh P; Linker A; Border WA
    Kidney Int; 1988 Feb; 33(2):517-23. PubMed ID: 2452273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.